Leica Bond Rx Controller

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on January 29, 2026.

Award Information

This solicitation resulted in an award to for approximately $30,500 on January 29, 2026. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 811210 (Electronic and Precision Equipment Repair and Maintenance).

Award Number
75N91026P00006
Award Amount
$30,500
Award Date
January 29, 2026

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Set-aside for No Set Aside businesses
  • Work to be performed in ROCKVILLE, MD
  • Industry: Electronic and Precision Equipment Repair and Maintenance

Contract Details

Notice ID
75N91026P00006
Opportunity Type
Award Notice
Sub-Agency
OFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)
Office
PROGRAM SUPPORT CENTER ACQ MGMT SVC
Posted Date
Friday, February 6, 2026
Response Deadline
Not specified
PSC Code
Q515
Set-Aside
No Set Aside
Place of Performance
ROCKVILLE, MD, 20857
Status
Active

Description

This is a Firm Fixed Price Purchase Order. The National Cancer Institute (NCI) awarded a purchase order to Ferox LLC to obtain a Bond Rx Controller for a clinical instrument (Leica Bond) Automated Immunohistochemistry stainer annual (1 year warranty included) and recommended Preventative Maintenance post-instrument relocation (with PM Kit included). The instrument will be used for validation of clinical IHC target markers for diagnostic and in some cases enrollment to NIH clinical trials. In the clinical research application, the Bond Rx instrument will be used for critical research in rare tumor identification and subsequent development of therapeutic mechanisms for patients undergoing treatments.

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for electronic and precision equipment repair and maintenance with a set-aside for No Set Aside businesses in ROCKVILLE, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.